Manus Bio Overview

  • Founded
  • 2011

Founded
  • Status
  • Private

  • Employees
  • 140

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2M

  • Investors
  • 23

Manus Bio General Information

Description

Developer of an advanced fermentation technology designed to recreate plant processes in microorganisms to produce natural ingredients through fermentation. The company's technology helps in manufacturing complex and bioactive natural products such as flavors, fragrances, food ingredients, bio-pesticides, and pharmaceuticals, enabling businesses to make affordable and sustainable products.

Contact Information

Formerly Known As
Manus Biosynthesis, Manus Biosynthesis, Inc.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Agricultural Chemicals
Other Agriculture
Multi-line Chemicals
Primary Office
  • 1030 Massachusetts Avenue
  • Suite 300
  • Cambridge, MA 02138
  • United States
+1 (706) 000-0000

Manus Bio Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Manus Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Grant 31-Aug-2022 $2M 00000 Completed Generating Revenue
15. Debt - General 09-May-2022 0000 00000 Completed Generating Revenue
14. Debt - General 20-Aug-2021 0000 00000 Completed Generating Revenue
13. Later Stage VC (Series B) 06-Nov-2020 0000 000.00 00000 Completed Generating Revenue
12. Debt - PPP 15-Apr-2020 00000 000.00 Completed Generating Revenue
11. Later Stage VC (Series A1) 05-Jun-2018 00.00 000.00 0000 Completed Generating Revenue
10. Grant 11-Jan-2018 00000 000.00 Completed Generating Revenue
9. Grant 01-Jan-2018 00000 000.00 Completed Generating Revenue
8. Grant 01-Jan-2018 $100K $12.7M Completed Generating Revenue
7. Later Stage VC (Series A) 29-Dec-2017 $9.1M $12.7M 000.00 Completed Generating Revenue
To view Manus Bio’s complete valuation and funding history, request access »

Manus Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B3 000,000 00.000000 00 000.0 000.0 00 000.0 0.000
Series B2 00,000 00.000000 00 000.00 000.00 00 000.00 0.000
Series B1 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series A1 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series A 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Seed 2 616,765 $0.001000 5% $4.86 $4.86 1x $4.86 10.56%
Seed 1 88,951 $0.001000 10% $4.6 $4.6 1x $4.6 1.52%
To view Manus Bio’s complete cap table history, request access »

Manus Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an advanced fermentation technology designed to recreate plant processes in microorganisms to produce natur
Biotechnology
Cambridge, MA
140 As of 2022
00000
0000000000 00000

000 00

am, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
000000000 000000000
Boulder, CO
00 As of 0000
000.00
0000000000 0 000.00

000000

reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaeca
0000000000000
Bedford, MA
00 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Manus Bio Competitors (15)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DMC Biotechnologies Venture Capital-Backed Boulder, CO 00 000.00 0000000000 0 000.00
0000000 Private Debt Financed Bedford, MA 00 000000000 -
000000 Venture Capital-Backed Seattle, WA 00 000.00 00000000000 000.00
00000 Venture Capital-Backed Berkeley, CA 00 00000 000000&0 00000
000000 00000000 00 Formerly VC-backed Boston, MA 000 00.000 000000000 00.000
You’re viewing 5 of 15 competitors. Get the full list »

Manus Bio Patents

Manus Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3164769-A1 Microbial production of mogrol and mogrosides Pending 16-Dec-2019 0000000000
AU-2020408684-A1 Microbial production of mogrol and mogrosides Pending 16-Dec-2019 0000000000
US-11168309-B2 Uridine diphosphate-dependent glycosyltransferase enzyme Active 25-Jun-2019 0000000000
US-20220090031-A1 Uridine diphosphate-dependent glycosyltransferase enzyme Pending 25-Jun-2019 0000000000
US-20210009968-A1 Uridine diphosphate-dependent glycosyltransferase enzyme Active 25-Jun-2019 C12N9/1051
To view Manus Bio’s complete patent history, request access »

Manus Bio Executive Team (11)

Name Title Board Seat Contact Info
Ajikumar Parayil Ph.D Co-FounderChief Executive Officer & President
Jeremy Hux Chief Financial Officer
Christine Santos Chief Technology Officer
Brendan Naulty Chief Revenue Officer & Chief Commercial Officer
Jeffrey Anderson Chief Business Officer
You’re viewing 5 of 11 executive team members. Get the full list »

Manus Bio Board Members (10)

Name Representing Role Since
Byron Alsberg Prefix Capital Board Member 000 0000
Gregory Stephanopoulos Ph.D Manus Bio Co-Founder & Board Member 000 0000
Jeanmarie Desmond Self Board Member 000 0000
Kittiphong Limsuwannarot BBGI Board Member 000 0000
Michael Carlos Self Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Manus Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Manus Bio Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Abhijeet Birewar Angel (individual) Minority 000 0000 000000 0
Andrew Ervin Angel (individual) Minority 000 0000 000000 0
Andrew Rapkin Angel (individual) Minority 000 0000 000000 0
BBGI Corporation Minority 000 0000 000000 0
First Rice Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 23 investors. Get the full list »

Manus Bio Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 000000000 17-Nov-2020 00000 0000 Food Products 00000000
NutraSweet (Plant in Augusta, Georgia) 29-Jun-2018 Corporate Asset Purchase Buildings and Property 00000000
To view Manus Bio’s complete investments history, request access »